Kristiina MD Vuori insider trades: Inhibrx Biosciences (INBX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kristiina reports to the SEC
and 1 more company
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 3, 2024 | INBX | ↑ Buy | 6,667 | $15.00 | $100K | Direct | Oct 7, 2024 (4d) |
| Sep 11, 2024 | INBX | ↑ Buy | 6,636 | $15.07 | $100K | Direct | Sep 12, 2024 (1d) |
| Aug 29, 2024 | INBX | ↑ Buy | 7,140 | $14.00 | $100K | Direct | Sep 3, 2024 (5d) |
| Dec 12, 2016 | WBMD | ↓ Sell | 1,561 | $53.01 | $83K | Direct | Dec 13, 2016 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other INBX insiders
Open-market trades in the last 12 months
About Kristiina MD Vuori's insider trades
Kristiina MD Vuori is a director at Inhibrx Biosciences (INBX). Since Dec 12, 2016, Kristiina has reported 3 open-market purchases worth $300K and 1 sale worth $83K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (30 filings), shares returned to the company (3 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.